CRLBF - Trulieve Is No Longer A Sell (Rating Upgrade)
2024-06-19 23:13:28 ET
Summary
- Trulieve stock, downgraded from Strong Buy to Sell after rally, dropped 27% despite positive news.
- Trulieve valuation decent compared to other Tier 1 MSOs, target price increased to $15.26 based on 2025 projections.
- We are more optimistic about cannabis stocks and recommend other investment opportunities like Cresco Labs and WM Technology.
I had a Strong Buy on Trulieve (TCNNF) a year ago and then downgraded it to Neutral in January. In late March, I downgraded it to Sell after a massive rally, suggesting that the valuation relative to peers was too high ....
Trulieve Is No Longer A Sell (Rating Upgrade)